Cross-Sex Hormone Therapy May Be Linked To Increased Risk For Cardiovascular Disease.

reports that while “cross-sex hormone therapy (CSHT) is tied with improved psychological well being in transgender persons,” research suggests “it may come with an increased risk for cardiovascular disease.” In the “narrative review, CSHT was associated with increased cardiovascular (CVD) risk factors among transgender men (female to male), especially among those also on testosterone treatment.” Meanwhile, with regard to “transgender women (male to female), there is a link between CSHT with an increased risk for thromboembolism, they wrote.” The findings were published in the Annals of Internal Medicine. Hormone Tx Tied to CVD Risk in Transgender Adults Transgender health issues need more study https://www.medpagetoday.com/endocrinology/generalendocrinology/66836